IU faculty startup raises $163.2M
MBX Biosciences, Inc., a startup co-founded by Gill Chair Richard DiMarchi, recently raised $163.2 million in its U.S. initial public offering. The company aims to help individuals with endocrine and metabolic diseases such as chronic hypoparathyroidism live healthier lives.